|
Originally published In Press as doi:10.1074/jbc.M000910200 on June 13, 2000
J. Biol. Chem., Vol. 275, Issue 37, 28739-28749, September 15, 2000
Autocrine Action and Its Underlying Mechanism of Nitric Oxide on
Intracellular Ca2+ Homeostasis in Vascular Endothelial
Cells*
Jie
Chen,
Yuepeng
Wang ,
Yue
Wang,
Toshiaki
Nakajima,
Kuniaki
Iwasawa,
Hisako
Hikiji§,
Mie
Sunamoto¶,
Dong-Kug
Choi**,
Yutaka
Yoshida ,
Yoshiyuki
Sakaki**, and
Teruhiko
Toyo-oka
From the Second Department of Internal Medicine, the
§ Department of Oral and Maxillofacial Surgery, and the
** Human Genome Center, Institute of Medical Science, University of
Tokyo, Tokyo 113-0033, Japan, the ¶ Molecular Chemistry
Laboratory, Takeda Chemical Industries, Osaka 532-0024, Japan, and the
Department of Pharmacology, Niigata University,
Niigata 951-8122, Japan
Received for publication, February 3, 2000, and in revised form, June 6, 2000
 |
ABSTRACT |
The rise in cytosolic Ca2+
concentration (Ca2+i) in vascular endothelial cells
(ECs) activates the production and release of nitric oxide (NO). NO
modifies Ca2+i homeostasis in many types of
nonendothelial cells. However, its effect on endothelial
Ca2+i homeostasis at basal and excited states
remains unclear. In the present study, to elucidate the effect of NO on
basal Ca2+i, inositol 1,4,5-trisphosphate-induced
Ca2+i release (IICR) was blocked by expressing an
antisense against type-1 inositol 1,4,5-trisphosphate receptors or by
microinjecting heparin to individual ECs, and the effects of NO that
was released by and diffused from adjacent IICR-intact ECs were
recorded. After ATP or bradykinin stimulation, IICR-inhibited ECs
showed a marked reduction of basal Ca2+i, which was
abolished by
NG-monomethyl-L-arginine
monoacetate pretreatment. The reduction disappeared in sparsely
seeded ECs. Exogenous NO gas mimicked the effect of ATP or bradykinin
to reduce basal Ca2+i. Blocking plasma membrane
Ca2+-ATPase (PMCA), but not
Na+-Ca2+ exchange or sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase, suppressed the reduction, indicating
that the reduction resulted from a NO-dependent
potentiation of PMCA. To elucidate the effect of NO on elevated
Ca2+i, ATP-, bradykinin-, or thapsigargin-evoked
Ca2+i response in the presence and absence of NO
production was compared in adjacent IICR-intact ECs. NO was found to
potentiate PMCA, which, in turn, greatly attenuated agonist-evoked
Ca2+i elevation. NO also potentiated
Ca2+ influx, which markedly increased the sustained phase
of Ca2+i elevation and possibly NO production. NO
did not affect other Ca2+i-elevating and
Ca2+i-sequestrating components. Thus,
NO-dependent potentiation of PMCA is crucial for
Ca2+i homeostasis over a wide
Ca2+i range.
 |
INTRODUCTION |
Vascular endothelial cells
(ECs)1 play an important role
in the regulation of blood pressure and local blood flow. ECs respond to physical stimuli and blood-borne chemical signals with the production and release of vasoactive substances that directly affect
the tone of vascular smooth muscle cells (VSMCs) (1-4). Cytosolic free
Ca2+ concentration (Ca2+i) in ECs plays
a crucial role in these processes. For example,
Ca2+i elevation activates endothelial nitric-oxide
synthase to produce nitric oxide (NO) (5, 6), which is the most potent substance to decrease VSMC tone and proliferation. In ECs, a typical Ca2+i elevation evoked by G-protein-coupled
receptor agonists consists of an initial spike and a subsequent
sustained phase (7-9). The initial spike mainly originates from
inositol 1,4,5-trisphosphate (IP3)-induced Ca2+
release (IICR) from the endoplasmic reticulum, and the following sustained phase results from capacitative Ca2+ entry (CCE)
across into the plasma membrane (10, 11). In addition to these
Ca2+i-elevating parts, Ca2+i is
also regulated by Ca2+i-sequestrating components,
including Ca2+i uptake by sarcoplasmic/endoplasmic
reticulum Ca2+-ATPase (SERCA) (12, 13),
Ca2+i extrusion by plasma membrane Ca2+
ATPase (PMCA) (14-17), and Na+-Ca2+ exchange
(NCX) (16-18). Our previous studies have shown that IICR is essential
for the induction of CCE in ECs and that CCE plays an important role in
the continuous production of NO (7, 8). On the other hand, in a series
of nonendothelial cell types, NO has been reported to modify almost all
Ca2+i-elevating and
Ca2+i-sequestrating components (19, 20). NO
attenuates IICR at several steps, by inhibiting G-protein in VSMCs (21) and platelets (22), by inhibiting phospholipase in PC12 cells (23),
and by inhibiting IP3 receptors in VSMCs (24). The effects of NO on CCE vary among cell types (19, 20, 25-30); NO potentiates CCE
in pancreatic acinar cells (25-27) and colonic epithelial cells (28),
does not affect CCE in Jurkat T-lymphocytes (29) and embryonic kidney
cells (30), and inhibits CCE in platelets (31) and VSMCs (32).
Regarding the effects on Ca2+i sequestration, NO
potentiates PMCA (33, 34), NCX (35-37), and SERCA (32) in VSMCs,
platelets, and astrocytes. However, in ECs, the effect of NO on
Ca2+i homeostasis including
Ca2+i-elevating and
Ca2+i-sequestrating components remains unclear.
On the other hand, most of the published results so far have been
obtained by using exogenous NO. The effects on
Ca2+i homeostasis varied among NO donor, NO gas,
and endogenous NO, even in the same cell type (19, 20, 34, 38, 39). In
the present study, endogenous NO released from bovine aortic ECs was
used to clarify its effects on Ca2+i homeostasis by
a two-step protocol. First, to observe the effect of NO on basal
Ca2+i, IICR response was inhibited in individual
ECs by expressing antisense against type 1 IP3 receptor
(IP3R1) or by microinjecting heparin. Then the
effect of NO that was released by and diffused from adjacent cells on
basal Ca2+i of IICR-inhibited ECs was recorded
after ATP or bradykinin (BK) stimulation. As a result, NO caused a
marked reduction in basal Ca2+i. The reduction was
a result of a NO-dependent potentiation of
Ca2+i extrusion by PMCA, indicating that this
action is crucial for Ca2+i homeostasis at the
resting state. Second, to observe the effect of NO on
Ca2+i dynamics, ATP- or BK-evoked
Ca2+i response in the presence and absence of NO
production was compared in adjacent IICR-intact cells. It was found
that endogenous NO potentiated PMCA and CCE but did not affect
IP3 production, NCX, and SERCA. The potentiation of PMCA
greatly attenuated agonist-evoked Ca2+i elevation,
while the potentiation of CCE markedly increased the sustained phase of
Ca2+i elevation and possibly NO production.
 |
MATERIALS AND METHODS |
Culture of ECs--
ECs were enzymatically isolated from bovine
aorta, cultured, and identified as described previously (8). To avoid
fluctuation of results due to differences in cell number and growth
cycles, cells that reached confluence were subjected to starvation of fetal bovine serum (1%) for 24 h before experiments. Cells of 4-12 passages were used in this study.
Preparation of Antibodies to Isoforms of IP3 Receptor
and Immunoblotting--
Three peptides were synthesized according to
the amino acid sequence of the cytosolic C-terminal domain of human
type 1 (GHPPHMNVNPQQ(C)), type 2 ((C)LGSNTPHVNHHMPPH), and type 3 ((C)RQRLGFVDVQNCISR) IP3 receptors. All of them
were synthesized with an additional cysteine at their N- or C-terminal
to facilitate coupling reaction. The sequence for
IP3R1 is preserved in most species including
mouse and Xenopus (40). The sequences of the corresponding
domain in rats are identical except for substitutions of the underlined residues. Antibodies to each of the peptides were purified from rabbit
serum by affinity chromatography, and specificities were determined by
immunoblotting. After solubilizing the crude homogenate of cultured
ECs, SDS-polyacrylamide gel electrophoresis was performed in 6% gel.
Samples were then electrotransferred to nitrocellulose membranes using
a semidry blotter. Membranes were incubated with antibodies (× 200)
against type 1, 2, or 3 IP3 receptor. Subsequently, membranes were incubated with horseradish peroxidase-conjugated secondary antibodies. Antigens recognized by antibodies were detected by enhanced chemiluminescence (Amersham Pharmacia Biotech).
Partial Cloning of Bovine IP3R1 Gene,
Construction of Vector, and Transient Transfection of ECs--
Total
RNA from cultured bovine aortic ECs was used as a template to generate
first stand cDNA using an oligo(dT)18 primer. A
two-strand DNA fragment of the bovine IP3R1
gene was amplified by polymerase chain reaction from cDNA using
primers (upper, 5'-catcctaacggaacgagctc-3'; lower,
5'-catagcttaaagaggcagtct-3'). The single fragment obtained was inserted
into the pCRTMII TA cloning vector (Invitrogen)
and sequenced (Hitachi-5500). The fragment spanned 379 bases ( 197 to
+182) shared 94% homology with human and 93% homology with mouse in
the corresponding domain of the IP3R1 gene. The
fragment was then subcloned into pEGFPC1 (CLONTECH), and antisense
(pG.IP3R1-AS) or sense
(pG.IP3R1-S) orientation of the
insert was confirmed by sequencing. To reduce the intercellular
distance between transfectants and adjacent untransfected cells and to
decrease the transfection rate, we used 100% confluent ECs.
Transfection was done in a serum-free medium using a mixture of 1.33 µg of pG.IP3R1-AS and 3.3 µl of Lipofectin (Life Technologies, Inc.) per 1.2-mm diameter dish. This
method resulted in a low transfection rate of 4-6%.
pG.IP3R1-S was used as the control.
12-24 h after transfection, the medium was changed to Dulbecco's
modified Eagle's medium with 10% fetal bovine serum. Cells were used
for experiments 24 h after the medium was changed.
Buffer Solutions--
HEPES buffer solution, which contained 145 mM NaCl, 5 mM KCl, 1 mM
CaCl2, 0.5 mM MgCl2, 10 mM D-glucose, and 10 mM Hepes (pH 7.4), was utilized as the extracellular medium. The
Ca2+-free medium consisted of HEPES buffer solution in
which CaCl2 was replaced with EGTA (1 mM). To
block PMCA, we employed a buffer consisting of 115 mM NaCl,
5 mM KCl, 1 mM CaCl2, 20 mM MgCl2, 10 mM
D-glucose, and 10 mM Hepes (pH 8.8) (33).
For blockade of NCX, NaCl in the HEPES buffer was totally replaced with
145 mM choline chloride. For blockade of both PMCA and NCX,
La3+ (125 µM) was added to the
Na+-free HEPES buffer.
Cell Microinjection--
After loading fura-2/AM (4 µM, Molecular Probes, Inc., Eugene, OR) for 40 min, ECs
were rinsed and incubated in the Ca2+-free medium. Heparin
(Mr = 5000; Wako) dissolved in the vehicle (48 mM K2HPO4, 14 mM
Na2HPO4, 4.5 mM
KH2PO4, and 400 µM unesterified fura-2, pH 6.9) was injected into the perinuclear cytoplasm (Eppendorf 5171 micromanipulator and 5246 transjector, Hamburg). The injection volume into a cell was controlled by varying heparin concentration and
injecting pressure (5-80 mmH2O). Within 5 min after
the injection, the medium was changed to HEPES buffer solution
containing 1 mM Ca2+ and incubated further for
10 min to stabilize the injected cells.
Measurement of Ca2+i and Mn2+
influx--
ECs were stimulated by ATP, BK, ionomycin (IM), or
thapsigargin (TG). All of the four agonists were obtained from Sigma.
Ca2+i responses of transfected and untransfected
cells as well as heparin-injected and -uninjected cells in the same
observation field were individually analyzed by a two-dimensional
Ca2+i imaging system, as reported previously (8,
41). The absolute Ca2+i was calculated by comparing
the fluorescence ratios at both wavelengths obtained at maximum
Ca2+i (achieved by lysing the cells and saturating
fura-2 with Ca2+) and minimum Ca2+i
(achieved by chelating all free Ca2+ with EGTA) using the
following equation: Ca2+i = Kd × (R Rmin)/(Rmax R) × Sf2/Sb2. Kd is the
dissociation constant (224 nM for fura-2), and
Rmin and Rmax are the
F340/F380 ratios of the
Ca2+-free and Ca2+-bound forms. Sf2/Sb2
is the ratio of the fluorescence values at 380-nm excitation determined
at Rmin and Rmax,
respectively. Mn2+ (0.5 mM)-induced quenching
of fura-2 fluorescence was recorded at the excitation wavelength of 360 nm (F360) for measurement of the cation influx
rate. The percentage Mn2+ quenching was obtained from the
dynamic F360 divided by the basal F360.
Immunocytostaining--
ECs grown on CELLocate
coverslips (Eppendorf) were rinsed with phosphate-buffered saline (pH
7.4) (8) and then fixed in the same buffer plus 3.6% paraformaldehyde.
All subsequent steps were performed in
Ca2+/Mg2+-free phosphate-buffered saline; cells
were washed once for 2 min, permeabilized with 0.5% Triton X-100 for
10 min, and washed three times (5 min/wash). Endogenous peroxidase
activity was blocked by MetOH containing 0.3%
H2O2 for 10 min. Nonspecific staining was
reduced by incubating with 2% skim milk for 15 min before cells were
subjected to the antibody against IP3R1 (× 200) in the presence of 10% goat serum for 1 h at room
temperature. Then cells were incubated with biotinylated goat
anti-rabbit IgG, and peroxidase labeling was carried out with an
avidin-biotin complex kit (Vector Laboratories) and visualized by
0.05% 3,3'-diaminobenzidine with 0.01% H2O2
(42).
NO2 Determination and
Preparation of NO Gas Solution--
ECs were rinsed, and 0.2 ml of
each medium was sampled before and 3 min after the administration of BK
(500 nM) or 8 min after the addition of TG (1 µM). The amount of NO2
produced was assayed as NO2 , which was
determined by colorimetry after the Griess reaction, as reported
previously (8, 43). NO gas solution was prepared according to the
method described by Shikano (44). In brief, 50 ml of 50 mM
Tris-HCl, pH 7.4, was placed in a rubber-stoppered glass tube (300 ml).
The tube was evacuated under vacuum for 20 min at 25 °C and then
flushed with O2-free N2 for 20 min on ice; NO
gas (99.99%) was flushed through the tube to saturate the atmosphere, and then the tube was vortexed and placed on ice. After 20 min, atmospheric NO was removed by flushing with N2 for 20 min.
Saturated NO in buffer (about 3.3 mM) was diluted into
degassed buffer and was freshly prepared immediately before use.
Measurement of IP3 Production--
ECs were
incubated for 1 h in serum-free HEPES buffer solution and then
stimulated with 10 µM ATP or 500 nM BK for 15 and 120 s. Then the medium was removed, and an equal volume of
ice-cold 15% (v/v) trichloroacetic acid was added. The lysate was
collected and centrifuged for 15 min at 2000 × g at
4 °C. The supernatants were extracted three times with 10 volumes of
water-saturated diethyl ether and neutralized to pH 7.5 with
NaHCO3. The remaining IP3 was quantified
according to the protocol of the IP3
[3H]assay system (Amersham Pharmacia Biotech).
 |
RESULTS |
Effects of NO on Basal Ca2+i in IICR-inhibited
Transfectants--
Immunoblotting revealed that the antibody against
IP3R1 reacted with a single 260-kDa band in the
crude homogenate of cultured bovine aortic ECs (Fig.
1A). In contrast, neither type
2 nor type 3 IP3 receptor was detected. A pharmacological
study of Ca2+i dynamics revealed that ECs responded
weakly ( Ca2+i rise = 11 nM) to
caffeine (3-60 mM), with or without ryanodine pretreatment
(10-60 µM; data not shown). These results suggest that
IICR mediated by IP3R1, but not
Ca2+-induced Ca2+i release, could be
the major mechanism involved in Ca2+i release in
ECs.

View larger version (47K):
[in this window]
[in a new window]
|
Fig. 1.
Subtypes of IP3 receptor
expression (A), IP3R1
expression, two-dimensional images of Ca2+i
response, and Ca2+i dynamics induced by ATP or BK
in transfectants of
pG.IP3R1-AS
(B) and
pG.IP3R1-S
(C). A, the crude homogenates of
cultured bovine aortic ECs (lanes 1,
3, and 5), A7r5 cells (lanes
2 and 6), and Chinese hamster ovary cells
(lane 4) were electrophoresed on 6%
SDS-polyacrylamide gel. Each of the two strips was immunoblotted with
specific antibodies against type 1 (lanes 1 and
2), 2 (lanes 3 and 4), and
3 (lanes 5 and 6) IP3
receptors. B and C, a-f show
transfectants expressing reporter EGFP (a), fura-2-loaded
cells (b), two-dimensional images of basal
Ca2+i level (c), peak
Ca2+i response induced by ATP (10 µM;
d), and BK (500 nM; e) in the
presence of 1 mM Ca2+ and the
immunocytostaining of IP3R1 (f).
After wash-out of ATP for 30 min, cells were stimulated by BK.
g-h show Ca2+i dynamics in
transfectants and adjacent untransfected cells in response to ATP
(arrows; g) and BK (arrows;
h). Bar, 50 µm.
|
|
Of the 4-6% of cells that were successfully transfected with
pG.IP3R1-AS, 16% showed reduced
IP3R1 expression (data not shown), and 12%
showed almost complete inhibition of IP3R1
expression by immunocytostaining (Fig. 1B). On the other
hand, the surrounding untransfected cells and cells transfected with
pG.IP3R1-S demonstrated normal
staining, indicating that the reduction or complete inhibition of
IP3R1 expression was a specific effect of
pG.IP3R1-AS (Fig. 1, B
and C).
Individual transfectants surrounded by untransfected cells were
selected to measure Ca2+i handling. Of all of the
pG.IP3R1-AS transfectants, about
15 and about 12% demonstrated attenuated and complete inhibition of
Ca2+i response to ATP or BK, respectively. The
incompletely (data not shown) or completely (Fig. 1B)
inhibited Ca2+i response is consistent with
immunocytostaining results. Ca2+i dynamics in cells
with incomplete IICR inhibition exhibited a delayed and shortened
initial Ca2+i spike, with subsequent
Ca2+i reduction below the basal level after ATP
( Ca2+i = 74 ± 5 nM, Fig.
2A) or BK
( Ca2+i = 70 ± 7 nM)
stimulation. Ca2+i dynamics in cells with complete
IICR inhibition demonstrated not only no initial
Ca2+i spike but also marked
Ca2+i reduction immediately after ATP
( Ca2+i = 84 ± 5 nM; Figs.
1B and 2C) or BK ( Ca2+i = 73 ± 4 nM; Fig. 1B) stimulation. After a
wash-out of the first ATP solution followed by a 30-min equilibration
period, these Ca2+i reductions were reproducible by
secondary ATP stimulation (Fig. 2, A and C). On
the other hand, in pG.IP3R1-S
transfectants, ATP and BK induced a normal Ca2+i
response (Fig. 1C).

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 2.
ATP-induced Ca2+i
dynamics in pG.IP3R1-AS
transfectants in the presence of 1 mM
Ca2+. Shown are ATP (10 µM)-induced
Ca2+i dynamics in cells with incomplete
(A and B) and complete (C and
D) IICR inhibition with (B and D) and
without (A and C) pretreatment with
L-NMMA (1 mM) for 30 min between two ATP
applications (1st and 2nd, arrows).
L-NMMA was added to the medium throughout ATP stimulation
(n = 5-6).
|
|
Our previous study has shown that NO is produced upon stimulation with
ATP or BK, and ATP-induced NO production is reproducible and can be
blocked by L-NMMA in bovine aortic ECs (8). Therefore, Ca2+i reduction with or without NO production was
compared in the same cell. Cells that exhibited marked
Ca2+i reduction after the first ATP stimulation
were pretreated with L-NMMA (1 mM; Calbiochem)
for 30 min. This procedure dramatically attenuated
Ca2+i reduction ( Ca2+i = 16 ± 4 nM) at the second ATP stimulation (Figs. 2, B and D), suggesting that
Ca2+i reduction was caused by endogenous NO.
However, Ca2+i reduction was unchanged by
pretreatment with indomethacin (25 µM) for 30 min (data
not shown).
Effects of NO on Basal Ca2+i in IICR-inhibited
ECs by Microinjection of Heparin--
Since IICR inhibition induced by
pG.IP3R1-AS is a relatively slow
process, the effects of NO were further investigated in ECs where IICR
was directly inhibited by heparin. As shown in Fig.
3, cell 1, injected with 50 mg/ml of
heparin at 10 mm H2O, exhibited an incomplete inhibition of
the initial Ca2+i spike, with a subsequent
Ca2+i reduction below the basal level in response
to ATP stimulation. Cell 2 and cell 3, injected with 200 mg/ml of
heparin at 20 mm H2O, exhibited a complete inhibition of
the initial Ca2+i spike and, moreover, marked
Ca2+i reduction ( Ca2+i = 103 ± 4 nM), similar to that occurring in
pG.IP3R1-AS transfectants. The
reduction of Ca2+i in cells with complete IICR
inhibition was reproducible in the second ATP stimulation
( Ca2+i = 102 ± 4 nM, Fig. 3,
B and D). BK also induced
Ca2+i reduction in IICR-inhibited cells
( Ca2+i = 98 ± 4 nM). As shown
in Fig. 4A, microinjection of vehicle or heparin (200 mg/ml) had no effect on basal
Ca2+i during a 60-min follow up period.
Ca2+i reduction was induced only by the application
of an agonist, and it was unlikely that the nonspecific effects of
heparin were involved in the process. Cells that exhibited complete
IICR inhibition after the first ATP stimulation were pretreated with L-NMMA for 30 min. This procedure completely abolished the
marked Ca2+i reduction and led to nearly no
Ca2+i rise at the second ATP stimulation
( Ca2+i = 2 ± 4 nM; Fig.
4B). When heparin was injected into ECs that were plated at
a low density, no Ca2+i reduction was observed
after ATP (Fig. 4C) stimulation. Furthermore, in sparsely
seeded ECs, treatment with NO gas solution (3 µM) induced
Ca2+i reduction in cells injected with heparin
( Ca2+i = 38 ± 7 nM) as well as
the adjacent IICR-intact cells ( Ca2+i = 19 ± 5 nM; Fig. 4D). These findings demonstrated that the reduction of basal Ca2+i caused by NO
also occurred in heparin-injected cells.

View larger version (61K):
[in this window]
[in a new window]
|
Fig. 3.
Two-dimensional images of
Ca2+i responses and Ca2+i
dynamics induced by ATP in heparin-injected ECs in the presence of 1 mM Ca2+. A, cell position and
time-serial two-dimensional images of Ca2+i
responses to first ATP (1st ATP, 10 µM)
stimulation. Cell 1 (1), injected with 50 mg/ml heparin,
showed a delayed and attenuated Ca2+i rise. Cell 2 (2) and cell 3 (3), injected with 200 mg/ml
heparin, showed marked Ca2+i reduction. Shown is
the localization of ECs and Ca2+i responses at 10, 20, 35, and 90 s after ATP stimulation. B,
fura-2-loaded cells and time-serial images of Ca2+i
responses to second ATP (2nd ATP; 10 µM)
stimulation. Ca2+i rise was partially recovered in
cell 1 but remained suppressed in cell 2 and cell 3. Shown are images
of fura-2-loaded cells and Ca2+i responses at 5, 10, 35, and 90 s after ATP stimulation. C and
D, Ca2+i dynamics of cell 1 and cell 2 after ATP stimulation (arrow), respectively.
Ca2+i dynamics of cell 3, which is similar to that
of cell 2, is omitted (n = 4). Bar, 50 µm.
|
|

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 4.
Basal Ca2+i level and
ATP- and NO gas solution-induced Ca2+i response in
confluent or sparse ECs injected with heparin (200 mg/ml).
A, in confluent cells, after microinjection
(arrow) of vehicle (a; n = 6) or
heparin (b; n = 4), basal
Ca2+i was monitored for 60 min and compared with
that of adjacent uninjected cells (c; n = 16). B, in confluent cells, cell 1 (1), injected
with heparin, showed marked Ca2+i reduction after
ATP (10 µM) stimulation (b). Following a
wash-out of ATP, cells were pretreated with L-NMMA (1 mM) for 30 min. Ca2+i reduction was
abolished and recovered to the basal line after the second ATP
stimulation (c). a-d exhibit two-dimensional
images of fura-2-loaded cells (a), the
Ca2+i rise at 25 s after the first
(b) and second (c) ATP stimulation, and
Ca2+i dynamics (d; n = 4). C, in sparsely seeded ECs, cell 2 (2),
injected with heparin, showed no Ca2+i reduction
after ATP stimulation. a-c exhibit two-dimensional images
of fura-2-loaded cells (a), the Ca2+i
rise at 25 s (b) after ATP stimulation, and
Ca2+i dynamics (c; n = 2). D, in sparsely seeded ECs, cell 3 (3),
injected with heparin, shows Ca2+i reduction after
treatment with NO gas solution (3 µM). a-c
exhibit two-dimensional images of fura-2-loaded cells (a),
the peak reduction of basal Ca2+i at 10 s
(b) after treatment with NO, and Ca2+i
dynamics (c; n = 3). Bar, 100 µm.
|
|
Changes of Ca2+ Influx, Internal
Ca2+i Stores, and Ca2+i
Extrusion in IICR-inhibited ECs--
The reduction of basal
Ca2+i was reversible naturally (Fig.
5, A, a).
Mn2+ quenching showed that ATP-induced (Fig. 5A,
c) or BK-induced (data not shown) Ca2+ influx
was almost absent during the reduction. After removal of the agonist,
the reduction was restored relatively rapidly (Fig. 5A,
b), during which Ca2+ influx increased mildly
(Fig. 5A, c).

View larger version (21K):
[in this window]
[in a new window]
|
Fig. 5.
Recovery process of Ca2+i
reduction (A), ionomycin-releasable
Ca2+i stores (B), and
Ca2+i reduction after inhibition of SERCA
(C). A, in heparin-injected cells, ATP
(10 µM)-evoked Ca2+i reduction shows
a reversible process, naturally (a) or by ATP removal
(w.o.) (b). Coinciding with a and
b, c shows changes in Mn2+ (0.5 mM) quenching of IICR-inhibited cells (traces
1 and 2) and adjacent IICR-intact cells
(trace 3) with (traces 2 and 3) and without (trace 1) the
removal (arrows) of ATP. Note that after removal of
ATP, fresh medium contains 0.5 mM Mn2+.
B, heparin-injected cells show no difference in
Ca2+i release between direct IM application
(thin line) and IM application after ATP-induced
Ca2+i reduction (thick line,
a). In b, each column denotes the
mean ± S.E. of Ca2+i reduction
(black columns) and Ca2+i rise
induced by direct IM application (open columns) and IM
application after ATP-induced Ca2+i reduction
(stippled columns) in both
pG.IP3R1-AS transfectants and
heparin-injected cells. C, the transfectants of
pG.IP3R1-AS (a,
thin line) with complete IICR inhibition and adjacent
IICR-intact cells (thick line) were stimulated by ATP at
20 s after the addition of TG (1 µM). Note that
there was still an ATP-evoked Ca2+i reduction.
Coinciding with a, b denotes changes in
Mn2+ quenching after TG-ATP stimulation for IICR-inhibited
cells (thin line) and adjacent IICR-intact cells
(thick line). c denotes changes in
Mn2+ quenching after TG stimulation for IICR-inhibited
cells (thin line) and adjacent IICR-intact cells
(thick line). NS, no significance;
n = 4-7.
|
|
Next, the Ca2+i sequestration pathway through which
NO reduced basal Ca2+i was examined. First, we
investigated whether the reduction of Ca2+i was a
result of a NO-dependent potentiation of SERCA. In the
absence of Ca2+, ATP- or BK-induced
Ca2+i release is caused by IICR, and further
Ca2+i release induced by IM represents the residual
content of internal Ca2+i stores. In
pG.IP3R1-AS transfectants and cells
injected with heparin, no significant increase in IM-releasable stores was found in between cells that showed marked Ca2+i
reduction after ATP stimulation and cells that were directly stimulated
by IM (Fig. 5B). Cells used in the study of direct IM
stimulation demonstrated an ATP-induced Ca2+i
reduction 30 min prior to IM addition. Furthermore, at 20 s after
TG addition, ATP (Fig. 5C, a) or BK (data not
shown) still induced a reduction of basal Ca2+i.
The reduction, however, is attenuated compared with the case without
TG. In IICR-inhibited cells, TG induced Ca2+i
elevation in the Ca2+-free medium (data not shown).
TG-ATP-induced (Fig. 5C, b) or TG-induced (Fig.
5C, c) Mn2+ quenching increased,
compared with ATP-induced quenching (Fig. 5A, c).
Thus, the attenuation of Ca2+i reduction might be
caused by the counteraction of the reduction by TG-induced
Ca2+ leakage from ER and TG-induced Ca2+
influx. These results proved that Ca2+i reduction
in IICR-inhibited cells was not caused by SERCA stimulation.
Second, we investigated whether the reduction of basal
Ca2+i was a result of NO-dependent
Ca2+i extrusion by PMCA
(Na+-independent Ca2+i efflux) or NCX
(Na+-dependent Ca2+i
efflux). Blockade of PMCA by 20 mM extracellular
Mg2+ (pH 8.8; Fig.
6A) almost completely
abolished the NO-induced Ca2+i reduction
( Ca2+i = 82 ± 4 nM; 8 ± 5 nM) in IICR-inhibited cells. Blockade of NCX by replacing
extracellular Na+ with choline did not affect the reduction
( Ca2+i = 82 ± 4 nM; 80 ± 6 nM; Fig. 6B). Blockade of both PMCA and NCX by
125 µM La3+ and 0 mM
Na+ also eliminated the reduction
( Ca2+i = 82 ± 4 nM; 11 ± 6 nM; Fig. 6C). To rule out the possibility that
these blockades might decrease NO production in adjacent IICR-intact
cells, NO2 production was assayed.
Even with the blockade of PMCA and/or NCX, NO was produced during BK
stimulation (Fig. 6D). Thus, Ca2+i
reduction in IICR-inhibited cells was caused by the NO-dependent potentiation of Ca2+i
extrusion by PMCA.

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 6.
Effects of PMCA or NCX blockade on the
Ca2+i reduction in IICR-inhibited cells and NO
production from adjacent IICR-intact cells in the presence of 1 mM Ca2+. A,
pG.IP3R1-AS transfectants showed
Ca2+i reduction upon ATP (10 µM,
thick line) stimulation. After wash-out of ATP for 30 min,
cells were stimulated by BK (500 nM, thin line)
under the blockade of PMCA by 20 mM Mg2+ (pH
8.8). B, pG.IP3R1-AS
transfectants showed Ca2+i reduction upon ATP
(thick line) stimulation. After wash-out of ATP, cells were
stimulated by BK (thin line) under the blockade of NCX by 0 mM Na+. C, under the blockade of NCX
by 0 mM Na+,
pG.IP3R1-AS transfectants showed
Ca2+i reduction upon ATP (thick line)
stimulation. After wash-out of ATP, cells were stimulated by BK
(thin line) under the blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+.
D, effect of PMCA or NCX blockade on BK-induced NO
production in IICR-intact cells. Each column denotes the
mean ± S.E. *, p < 0.05 between the presence and
absence of L-NMMA (1 mM) (n = 4-7).
|
|
Effects of NO on Agonist-evoked Ca2+i Elevation
in Adjacent IICR-intact ECs--
The effects of NO on agonist-evoked
Ca2+i elevation were investigated by comparing
Ca2+i response in the presence and absence of NO
production. Inhibition of NO production by L-NMMA
significantly potentiated the initial spike in the presence and absence
of 1 mM Ca2+ (Figs.
7, A and B, and 8,
A and B, and Table
I). Our previous study has proven
that NO is produced in the Ca2+-free medium after ATP or BK
stimulation, although the amount produced is less than that produced in
the presence of 1 mM Ca2+ (8).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of NO on the sustained phase of
Ca2+i dynamics and Ca2+ influx with and
without blockade of PMCA or NCX in IICR-intact ECs in the presence of 1 mM Ca2+. The upper
panel shows Ca2+i dynamics in response
to ATP (10 µM; A) and BK (500 nM;
B-D) with (thin solid line) or without
(thick solid line) pretreatment with L-NMMA (1 mM). Coinciding with the upper panel,
the lower panel shows Ca2+ influx in
response to ATP (E) and BK (F-H) with
(thin solid line) or without (thick solid line)
pretreatment with L-NMMA. Furthermore, in B and
F, cells were stimulated under the blockade of PMCA by 20 mM Mg2+ (pH 8.8) with (thin dotted
line) or without (thick dotted line) pretreatment with
L-NMMA. In C, D, G, and
H, cells were stimulated under the blockade of NCX by 0 mM Na+ with (thin dotted line) or
without (thick dotted line) pretreatment with
L-NMMA. In D and H, cells were
stimulated under the blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+
with (thin gray solid line) or without (thick gray
solid line) pretreatment with L-NMMA. Mn2+
(0.5 mM) was simultaneously applied to cells with stimuli
(arrows) (n = 6-10).
|
|
View this table:
[in this window]
[in a new window]
|
Table I
Modification of intracellular Ca2+i dynamics of ECs by
NO
Agonist actions were examined in the presence of 1 mM
extracellular Ca2+ (Ca2+ (+) or after chelating with 1 mM EGTA without the addition of Ca2+ (Ca2+
( )). The peak Ca2+i (Peak) and Ca2+i
level at 90, 210, or 240 s after the addition of an agonist is
expressed in nM. Mn2+ quenching at 210 s
(Mn2+-210 s) is expressed as the percentage of change from the
basal level. After ATP or BK stimulation in Ca2+ ( ), the peak
of the residual Ca2+i release induced by ionomycin
(Peak-IM) is expressed in nM. Each value indicates the
mean ± S.E. (n = 7-14). L-NMMA was
applied 30 min prior to stimulation. TG-ATP and TG-BK, cells were
treated with TG at 20 s before ATP and BK stimulation,
respectively.
|
|
First, the mechanism of NO-dependent attenuation of the
initial Ca2+i spike was investigated. The effect of
NO on ATP- or BK-induced IP3 production was measured by
radioimmunoassay. The basal IP3 concentration was 0.7 ± 0.1 µM in ECs. In the Ca2+-free medium,
ATP- and BK-induced IP3 concentrations were 2.8 ± 0.3 and 2.9 ± 0.3 at 15 s and 2.7 ± 0.4 and 2.9 ± 0.4 µM at 120 s after stimulation, respectively
(n = 4). After L-NMMA pretreatment, ATP-
and BK-induced IP3 concentrations were 2.9 ± 0.4 and
3.1 ± 0.3 at 15 s and 2.8 ± 0.4 and 3.0 ± 0.7 µM at 120 s after stimulation, respectively
(n = 4). Therefore, IP3 concentration was
not significantly changed in cells with and without pretreatment with
L-NMMA after both ATP and BK stimulus. This indicates that
NO did not inhibit IP3 production in ECs.
Even after the initial Ca2+i spikes were attenuated
by NO in the Ca2+-free medium, IM-induced residual
Ca2+ release was not significantly changed (Fig.
8, Table I). Furthermore, TG (1 µM) was used at 20 s before treatment with ATP or BK
in the Ca2+-free medium. Under the inhibition of SERCA,
L-NMMA pretreatment still potentiated the agonist-evoked
initial Ca2+i spike (Fig.
9A, Table I), suggesting that
NO did not potentiate SERCA.

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 8.
Effects of NO on initial
Ca2+i spike and IM-releasable residual
Ca2+i stores in IICR-intact cells in
Ca2+-free medium. Shown is the initial
Ca2+i spike in response to ATP (10 µM; A) or BK (500 nM;
B) and then to ionomycin (1 µM)
(n = 4-10).
|
|

View larger version (23K):
[in this window]
[in a new window]
|
Fig. 9.
Effects of NO on Ca2+i
extrusion mediated by PMCA or NCX after blockade of SERCA in
IICR-intact cells in Ca2+-free medium. Shown is the
initial Ca2+i spike evoked by TG and BK
(upper panel) or TG only (lower
panel) after blockade of PMCA by 20 mM
Mg2+ (pH 8.8; A and D), blockade of
NCX by 0 mM Na+ (B and
E), and blockade of both PMCA and NCX by 125 µM La3+ and 0 mM Na+
(C and F). In the upper
panel, cells were treated with TG (1 µM)
at 20 s before BK (500 nM) stimulation
(n = 6-10).
|
|
The following studies were addressed to investigate the
NO-dependent potentiation of Ca2+i
extrusion. In the presence of 1 mM Ca2+, the
effect of NO on BK-induced Ca2+ dynamics was observed after
the blockade of PMCA or NCX, while the SERCA mechanism remained
operational. Blockade of PMCA by 20 mM Mg2+ (pH
8.8) significantly raised BK-induced Ca2+i
elevation, decreased Ca2+ influx, and slightly attenuated
NO production (Figs. 6D and 7, B and
F, and Table I). Under the blockade of PMCA,
L-NMMA pretreatment did not markedly influence these
effects (Fig. 7, B and F, and Table I). In
contrast, blockade of NCX by 0 mM Na+
demonstrated no prominent effect on the initial spike, the sustained phase, and the Ca2+ influx (Figs. 7, C and
G). Under the blockade of NCX, L-NMMA pretreatment mildly potentiated Ca2+i elevation.
Blockade of both PMCA and NCX by 0 mM Na+ and
125 µM La3+ raised BK-induced
Ca2+i elevation, decreased Ca2+ influx,
and attenuated NO production (Fig. 7, D and H,
Table I). Under the blockade of both PMCA and NCX, L-NMMA
pretreatment did not markedly influence these effects. These results
indicated that the NO-dependent potentiation of PMCA might
be involved in Ca2+i extrusion while
Ca2+i is elevated by agonist stimulation.
To prove this hypothesis, we investigated the effect of NO after
further inhibition of SERCA by TG (1 µM) at 20 s
before BK treatment in the Ca2+-free medium. Blockade of
PMCA by 20 mM Mg2+ (pH 8.8) significantly
raised the BK-induced initial Ca2+i spike (Fig.
9A, Table I). Under the blockade of PMCA, further inhibition
of NO production did not change the potentiation of the BK-induced
Ca2+i spike. On the other hand, blockade of NCX
showed no significant effect on the BK-induced
Ca2+i spike (Fig. 9B, Table I). Under
the blockade of NCX by 0 mM Na+, further
inhibition of NO production mildly potentiated the BK-induced Ca2+i spike. Blockade of both PMCA and NCX by 0 mM Na+ and 125 µM
La3+ markedly raised the Ca2+i spike
(Fig. 9C). Under the blockade of both PMCA and NCX,
L-NMMA pretreatment did not markedly influence these
effects. Similar results were obtained by using TG only, to inhibit
SERCA and to stimulate Ca2+i rise and NO production
in the Ca2+-free medium (Fig. 9, D-F). NO was
produced during TG stimulation even in the presence of PMCA and/or NCX
blockade (Fig. 10). These results
strongly indicate that the attenuation in the initial Ca2+i spike is caused by the
NO-dependent potentiation of PMCA, which plays an important
role in attenuating Ca2+i signal in the excited
state.

View larger version (27K):
[in this window]
[in a new window]
|
Fig. 10.
TG-induced NO production in IICR-intact
cells in Ca2+-free medium. Shown is the effect of PMCA
or NCX blockade on TG (1 µM)-induced NO production. Each
column denotes the mean ± S.E. *, p < 0.05 between the presence and absence of L-NMMA (1 mM). (n = 4-6).
|
|
Second, in contrast to attenuating the initial
Ca2+i spike, NO significantly increased the
sustained Ca2+i phase (Fig. 7, A and
B, Table I). As shown by Mn2+ quenching of
fluorescence, NO markedly potentiated Ca2+ influx
(from 17 ± 3 to 30 ± 3% at 210 s after ATP
stimulation, p < 0.05; from 18 ± 3 to 27 ± 4% at 210 s after BK stimulation, p < 0.05; Fig.
7, E and F, and Table I). The potentiated
Ca2+ influx coincided with the sustained phase of
Ca2+i transients. These results suggest that
endogenous NO maintains Ca2+i elevation during the
sustained phase by promoting CCE.
 |
DISCUSSION |
The major findings of the present study are as follows. 1) There
is marked reduction of basal Ca2+i after ATP or BK
stimulation in individual ECs in which IICR and the subsequent CCE are
inhibited by expressing an antisense against
IP3R1 or microinjecting heparin. 2) The
reduction of Ca2+i results from NO that was
released by and diffused from adjacent IICR-intact ECs. 3) NO reduces
basal Ca2+i by potentiation of
Ca2+i extrusion by PMCA. 4) This potentiation also
markedly attenuates agonist-evoked Ca2+i elevation
in adjacent IICR-intact cells. 5) Endogenous NO markedly promotes
agonist-evoked CCE, which maintains Ca2+i elevation
and possibly NO production in ECs.
Crucial Role of NO-dependent Potentiation of PMCA in
Basal Ca2+i Homeostasis--
NO donor or NO
gas has been widely used to mimic the effect of endogenous NO (19, 20).
However, their effect on basal Ca2+i has been
controversial because of conflicting results. In platelets, Johansson
et al. (34) reported that sodium nitroprusside (SNP; 20 µM) reduces basal Ca2+i by 20-23
nM. In contrast, in ECs, Volk et al. (38) reported that SNP (10-1000 µM) significantly increases
Ca2+i up to about 200% of the basal level
( Ca2+i = 300 nM), similar to the
Ca2+i rise induced by 10 µM ATP.
Actually, our group also confirmed that 100-300 µM SNP,
and not 1-30 µM SNP, mildly increases basal
Ca2+i by 10-20 nM in both ECs and
VSMCs. However, its nonspecific Ca2+i-raising effect, which is produced by
its intermediate or metabolized compounds, could not be excluded from
the results, since the Ca2+i rise could not be
inhibited by methemoglobin (50 µM).2 In
platelets, Sang et al. (39) reported that a high (5 µM) and not a low concentration of NO gas solution (0.1 µM) increases basal Ca2+i by 10 nM.
On the other hand, our previous studies have shown that after ATP
stimulation, endogenous NO that is released by and diffused from ECs
decreases basal Ca2+i in adjacent VSMCs by about
40-90 nM in the coculture of both cells (8, 41). The
results are consistent with the physiological effect of NO on VSMCs.
However, a similar analysis of the effect of endogenous NO on basal
Ca2+i in ECs is difficult because agonist-evoked
Ca2+i elevation is needed for NO production.
Although antagonists against receptor (45), G-protein (46), or
phospholipase (47) are able to inhibit Ca2+i
elevation, they are inadequate for the analysis, since these treatments
in a culture dish inhibited Ca2+i elevation in all
ECs and consequently led to a decrease in NO production. The effect of
NO may only be analyzed in individual ECs in which agonist-evoked
Ca2+i elevation is inhibited. In the present study,
by using individual ECs in which agonist-evoked
Ca2+i elevation was inhibited by the antisense or
heparin and by using adjacent excited ECs as a source of NO production, the potent effect of endogenous NO on reducing basal
Ca2+i was successfully elucidated. The reduction of
basal Ca2+i by endogenous NO has been
substantiated, including the partial mimicry by exogenous NO gas. Our
studies suggested that endogenous NO is the most ideal source for
exploring the physiological effect of NO. NO donor or even NO gas does
not always act in the same way as endogenous NO because of difficulty
in maintaining the narrow range of effective concentration and
mimicking the diffusion pattern of NO in vivo.
The mechanism involved in the reduction of basal
Ca2+i was clarified. Our results excluded the
involvement of NO-dependent potentiation of SERCA, since
there was no consequent increase in IM-releasable
Ca2+i stores after the reduction of basal
Ca2+i (Fig. 5B), and ATP or BK still
induced Ca2+i reduction after SERCA was blocked
(Fig. 5C). After blocking SERCA, the attenuation of
Ca2+i reduction could be explained by the
counteraction by TG-induced Ca2+ leakage from internal
stores and TG-induced CCE. The remaining hypothesis is that NO
potentiates Ca2+i extrusion by PMCA or NCX.
Recently, there is increasing evidence that PMCA is important for
Ca2+i extrusion, while NCX plays a minor role
(14-18). Thus, the effects of blocking PMCA or NCX on
Ca2+i reduction in IICR-inhibited cells were
investigated. It was reported that extracellular increase in pH to 8.8 blocks the activity of PMCA in squid axons and red cells, does not
alter the activity of NCX and SERCA, and minimally changes
intracellular pH (33, 35, 48, 49). Increasing extracellular
Mg2+ concentration to 20-30 mM can also block
the activity of PMCA in red cells and VSMCs (33, 35, 49). The
combination of 20 mM Mg2+ and pH 8.8 blocks
PMCA-mediated Ca2+i efflux by up to 80% in VSMCs,
whereas it did not affect NCX (33, 35, 50). That PMCA can be blocked by
20 mM Mg2+ (pH 8.8) from the side opposite to
the ATP-binding site of the membrane holds true not only for the case
in VSMCs but is a general property of the membrane Ca2+
pump ATPase (33, 35, 48-51). Furthermore, extracellular
La3+ at concentrations of 60-250 µM
specifically blocks PMCA but spares NCX in red cells and VSMCs
(IC50 = 50-65 µM; Refs. 33 and 52). Low concentrations of La3+ (20-100 µM)
inhibit PMCA activity by displacing Mg2+ from the site at
which it combines to accelerate dephosphorylation (53). Therefore,
these methods were used to block PMCA of ECs in the present study. On
the other hand, NCX was blocked by a Na+-free buffer. The
extracellular Na+-free buffer would induce changes in
intracellular conditions, which, in turn, could affect the activity of
PMCA indirectly. However, a previous study showed that the
extracellular Na+-free buffer caused a decrease in
intracellular Na+ concentration by 30% in VSMCs (33). Such
a decrease in Na+ concentration did not affect the activity
of PMCA significantly, since intracellular Na+ and
K+ substituted for each other in activating PMCA (54).
Several studies have revealed the function of PMCA under the inhibition of NCX using the same method (32, 33, 35, 48-51).
Consequently, Ca2+i reduction was suppressed after
the blockade of PMCA but still occurred after the blockade of NCX in
IICR-inhibited cells (Fig. 6). These blockades did not significantly affect BK-induced NO production by adjacent IICR-intact cells. Thus,
Ca2+i reduction results from the
NO-dependent potentiation of Ca2+i
extrusion by PMCA, which may be a major and potent regulator of basal
Ca2+i homeostasis in ECs. Our results are
consistent with previous reports for VSMCs and platelets. In VSMCs,
Furukawa et al. (33) reported that SNP or 8-Br-cGMP markedly
accelerated the Ca2+i extrusion by PMCA,
especially at basal Ca2+i level. In platelets,
Johansson et al. (34) reported that both SNP (10 µM) and dibutyryl-cGMP (1 mM)
significantly increased Vm of PMCA without affecting its
Km or Hill coefficient. SNP or dibutyryl-cGMP,
however, did not change the rate of NCX that has a minor contribution
to basal Ca2+i extrusion. As a result of
potentiation of PMCA, SNP or dibutyryl-cGMP decreased the basal
Ca2+i and attenuated the ionomycin-induced
Ca2+i elevation. These effects resulted from a
cGMP-induced phosphorylation of PMCA (34).
NO Potentiates PMCA as Well as CCE during Agonist
Stimulation--
NOdependent potentiation of PMCA is also
important for Ca2+i extrusion during the BK- or
TG-evoked Ca2+i elevation (Fig. 9). As indicated by
its action on the basal Ca2+i (70-150
nM), the TG-evoked Ca2+i elevation
(200-260 nM), and the ATP- or BK-evoked
Ca2+i elevation (~600 nM),
NO-dependent potentiation of PMCA functions to extrude
Ca2+i over a wide Ca2+i range.
Therefore, the potentiation may be crucial for the normal function of
ECs. As regards NCX, our results indicated that it also plays a minor
role during agonist-evoked Ca2+i elevation,
consistent with the results of previous studies (16, 55, 56).
The present study also showed the significant potentiation of CCE by
NO. The lifetime of NO spans only about 6 s (57), suggesting that
the potentiation was not due to the NO produced during initial Ca2+i spike but rather to the NO produced during
the sustained Ca2+i phase. As shown in Fig. 7, the
potentiation is necessary for the maintenance of
Ca2+i elevation during the sustained phase, where
IICR is decreased and PMCA still functions to decrease
Ca2+i. Our group and others have reported the
importance of CCE in NO production (7, 8, 58). The mechanism was explained by the ability of endothelial nitric-oxide synthase to
be directly activated by Ca2+ influx, based on
immunostaining findings that endothelial nitric-oxide synthase is
locally linked to caveolin beneath the plasma membrane (5). The
potentiation of CCE by endogenous NO may contribute to the continuous
NO production during the sustained phase. By summing up these results,
we extrapolate that the Ca2+i elevation and
continuous NO production during the sustained phase might be maintained
by a positive feedback mechanism between NO production and
Ca2+ influx. The feedback mechanism explains clearly the
continuous NO production during the sustained phase (7, 8, 58).
In conclusion, the present study revealed that endogenous NO modifies
Ca2+i signal in ECs by potentiating PMCA and CCE.
At the basal state and during the initial Ca2+i
spike after agonist stimulation, NO potentiates PMCA, which contributes
to keep the basal Ca2+i level low and buffer the
rapid Ca2+i rise induced by agonists. During the
sustained Ca2+i phase, apart from potentiating
PMCA, NO mainly potentiates CCE, which keeps the
Ca2+i level elevated and possibly enhances NO production.
 |
ACKNOWLEDGEMENTS |
We are grateful to Dr. Masamitsu Iino
(Department of Pharmacology) and Dr. Katsuhiko Mikoshiba (Department of
Molecular Neurobiology, Institute of Medical Science) of the University
of Tokyo for expert assistance during the course of this study.
 |
FOOTNOTES |
*
This work was supported by grants-in-aid from the Ministry
of Education, Science and Culture, the Ministry of Health and Welfare of Japan, the Research Foundation for Health Science, the
Japanese-Chinese Medical Research Collaboration Foundation, the
Research Foundation of the Japan Society for the Promotion of Science,
the Kanehara-ichiro Foundation, and the Uehara Memorial Foundation.The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
To whom correspondence should be addressed: The Second Dept. of
Internal Medicine, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, Tokyo
113-0033, Japan. Tel.: 81-3-5449-5625; Fax: 81-3-5449-5445; E-mail:
srwang-tky@umin.ac.jp.
Published, JBC Papers in Press, June 13, 2000, DOI 10.1074/jbc.M000910200
2
J. Chen, Y. Wang, Y. Wang, T. Nakajima, K. Iwasawa, H. Hikiji, M. Sunamoto, D. K. Choi, Y. Yoshida, Y. Sakaki, and
T. Toyo-oka, unpublished data.
 |
ABBREVIATIONS |
The abbreviations used are:
EC, endothelial
cell;
BK, bradykinin;
Ca2+i, intracellular
Ca2+;
CCE, capacitative Ca2+ entry;
IICR, inositol 1,4,5-trisphosphate-induced Ca2+i release;
IM, ionomycin;
IP3, inositol 1,4,5-trisphosphate;
IP3R1, type 1 IP3 receptor;
L-NMMA, NG-monomethyl-L-arginine
monoacetate;
NCX, Na+-Ca2+ exchange;
NO, nitric
oxide;
PMCA, plasma membrane Ca2+-ATPase;
SERCA, sarcoplasmic/endoplasmic reticulum Ca2+-ATPase;
TG, thapsigargin;
VSMC, vascular smooth muscle cell.
 |
REFERENCES |
| 1.
|
Vane, J. R.,
Anggard, E. E.,
and Botting, R. M.
(1990)
N. Engl. J. Med.
323,
27-36
|
| 2.
|
Furchgott, R. F.,
and Zawadzi, J. V.
(1980)
Nature
288,
373-376
|
| 3.
|
Palmer, R. Y. J.,
Ferrige, A. G.,
and Moncada, S.
(1987)
Nature
327,
524-526
|
| 4.
|
Vanhoutte, P. M.,
and Shimokawa, H.
(1989)
Circulation
80,
1-9
|
| 5.
|
Forstermann, U.,
Pollock, J. S.,
Schmidt, H. H. H. W.,
Heller, M.,
and Murad, F.
(1993)
Proc. Natl. Acad. Sci. U. S. A.
88,
1788-1792
|
| 6.
|
Marletta, M. A.
(1994)
Cell
78,
927-930
|
| 7.
|
Luckhoff, A.,
Pohl, U.,
Mulsch, A.,
and Busse, R.
(1988)
Br. J. Pharmacol.
95,
189-196
|
| 8.
|
Wang, Y. P.,
Shin, W. S.,
Kawaguchi, H.,
Inukai, M.,
Kato, M.,
Sakamoto, A.,
Uehara, Y.,
Miyamoto, M.,
Shimamoto, N.,
Korenaga, R.,
Ando, J.,
and Toyo-oka, T.
(1996)
J. Biol. Chem.
271,
5647-5655
|
| 9.
|
Wang, Y. P.,
Chen, J.,
Shin, W. S.,
Kawaguchi, H.,
Inukai, M.,
and Toyo-oka, T.
(1996)
Circulation
94,
I-713
|
| 10.
|
Berridge, M. J.
(1993)
Nature
361,
315-325
|
| 11.
|
Berridge, M. J.
(1995)
Biochem. J.
312,
1-11
|
| 12.
|
Mountian, I.,
Manolopoulos, V. G.,
Smedt, H. D.,
Parys, J. B.,
Missiaen, L.,
and Wuytack, F.
(1999)
Cell Calcium
25,
371-380
|
| 13.
|
Morgan, A. J.,
and Jacob, R.
(1998)
J. Physiol. (Lond.)
513,
83-101
|
| 14.
|
Snitsarev, V. A.,
and Taylor, C. W.
(1999)
Cell Calcium
25,
409-417
|
| 15.
|
Klishin, A.,
Sedova, M.,
and Blatter, L. A.
(1998)
Am. J. Physiol.
274,
C1117-C1128
|
| 16.
|
Sedova, M.,
and Blatter, L. A.
(1999)
Cell Calcium
25,
333-343
|
| 17.
|
Goto, Y.,
Miura, M.,
and Iijima, T.
(1996)
Eur. J. Pharmacol.
314,
185-192
|
| 18.
|
Hansen, B. A.,
Batlle, D. C.,
and O'Donnell, M. E.
(1991)
Ann. N. Y. Acad. Sci.
639,
566-569
|
| 19.
|
Clementi, E.
(1997)
Trends. Pharmacol. Sci.
18,
266-269
|
| 20.
|
Clementi, E.
(1998)
Biochem. Pharmacol.
55,
713-718
|
| 21.
|
Hirata, M.,
Kohse, K. P.,
Chang, C. H.,
Ikebe, T.,
and Murad, F.
(1990)
J. Biol. Chem.
265,
1268-1273
|
| 22.
|
Nguyen, B. L.,
Saitoh, M.,
and Ware, A.
(1991)
Am. J. Physiol.
261,
H1043-H1052
|
| 23.
|
Clementi, E.,
Vecchio, I.,
Sciorati, C.,
and Nistico, G.
(1995)
Mol. Pharmacol.
47,
517-524
|
| 24.
|
Cavallini, L.,
Coassin, M.,
Borean, A.,
and Alexandre, A.
(1996)
J. Biol. Chem.
271,
5545-5551
|
| 25.
|
Xu, X,
Star, R. A.,
Tortoric, G.,
and Muallem, S.
(1994)
J. Biol. Chem.
269,
12645-12653
|
| 26.
|
Xu, X.,
Zeng, W.,
Diaz, J.,
Lau, K. S.,
Gukovskaya, A. C.,
Brown, R. J.,
Pandol, S. J.,
and Muallem, S.
(1997)
Cell Calcium
22,
217-228
|
| 27.
|
Gukovskaya, A. C.,
and Pandol, S. J.
(1994)
Am. J. Physiol.
266,
G350-G356
|
| 28.
|
Bischof, G.,
Brenman, J.,
Bredt, D. S.,
and Machen, T. E.
(1995)
Cell Calcium
17,
250-262
|
| 29.
|
Bian, X.,
Bird, G. S.,
and Putney, J. W., Jr.
(1996)
Cell Calcium
19,
351-354
|
| 30.
|
Bischof, G.,
Serwold, T. F.,
and Machen, T. E.
(1997)
Cell Calcium
21,
135-142
|
| 31.
|
Trepakova, E. S.,
Cohen, R. A.,
and Bolotina, V. M.
(1999)
Cir. Res.
84,
201-209
|
| 32.
|
Cohen, R. A.,
Weisbrod, R. M.,
Gericke, M.,
Yaghoubi, M.,
Bierl, C.,
and Bolotina, V. M.
(1999)
Circ. Res.
84,
210-219
|
| 33.
|
Furukawa, K.,
Tawada, Y.,
and Shigekawa, M.
(1988)
J. Biol. Chem.
263,
8058-8065
|
| 34.
|
Johansson, J. S.,
and Haynes, D. H.
(1992)
Biochim. Biophys. Acta
1105,
40-50
|
| 35.
|
Furukawa, K.,
Ohshima, N.,
Tawada, Y.,
and Shigekawa, M.
(1991)
J. Biol. Chem.
266,
12337-12341
|
| 36.
|
Takuma, K.,
Matsuda, T.,
Hashimoto, H.,
Kitanaka, J.,
Asano, S.,
Kishida, Y.,
and Baba, A.
(1996)
J. Neurochem.
67,
1840-1845
|
| 37.
|
Asano, S.,
Matsuda, T.,
Takuma, K.,
Kim, H. S.,
Sato, T.,
Nishikawa, T.,
and Baba, A.
(1995)
J. Neurochem.
64,
2437-2441
|
| 38.
|
Volk, T.,
Mading, K.,
Hensel, M.,
and Kox, W. J.
(1997)
J. Cell. Physiol.
172,
296-305
|
| 39.
|
Sang, K. H. L. Q.,
Lantoine, F.,
and Devynck, M. A.
(1996)
Br. J. Pharmacol.
119,
1361-1366
|
| 40.
|
Kume, S.,
Muto, A.,
Aruga, J.,
Nakagawa, T.,
Michikawa, T.,
Furuichi, T.,
Nakade, S.,
Okano, H.,
and Mikoshiba, K.
(1993)
Cell
73,
555-570
|
| 41.
|
Shin, W. S.,
Sasaki, T.,
Kato, M.,
Hara, K.,
Seko, A.,
Yang, W. D.,
Shimamoto, N.,
Sugimoto, T.,
and Toyo-oka, T.
(1992)
J. Biol. Chem.
267,
20377-20382
|
| 42.
|
Kawaguchi, H.,
Shin, W. S.,
Wang, Y. P.,
Inukai, M.,
Kato, M.,
Matsuo, Y. O.,
Sakamoto, A.,
Uehara, Y.,
Kaneda, Y.,
and Toyo-oka, T.
(1997)
Circulation
95,
2441-2447
|
| 43.
|
Yui, Y.,
Hattoti, R.,
Kosuga, K.,
Eizawa, H.,
Hiki, K.,
Ohkawa, S.,
Ohnishi, K.,
Terao, S.,
and Kawai, C.
(1991)
J. Biol. Chem.
266,
3369-3371
|
| 44.
|
Shikano, K.,
Long, C. J.,
Ohlstein, E. H.,
and Berkowitz, B. A.
(1988)
J. Pharmacol. Exp. Ther.
247,
873-881
|
| 45.
|
Uneyama, H.,
Uneyama, C.,
Ebihara, S.,
and Akaike, N.
(1994)
Br. J. Pharmacol.
111,
245-249
|
| 46.
|
Xu, X,
Zeng, W.,
and Muallem, S.
(1996)
J. Biol. Chem.
271,
11737-11744
|
| 47.
|
Strobaek, D.,
Olesen, S. P.,
Christophersen, P.,
and Dissing, S.
(1996)
Br. J. Pharmacol.
118,
1645-1652
|
| 48.
|
DiPolo, R.,
and Beauge, L.
(1982)
Biochim. Biophys. Acta
688,
237-245
|
| 49.
|
Kratje, R. B.,
Garrahan, P. J.,
and Rega, A. F.
(1985)
Biochim. Biophys. Acta
816,
365-378
|
| 50.
|
DiPolo, R.
(1978)
Nature
274,
390-392
|
| 51.
|
Wakabayashi, S.,
Ogurusu, T.,
and Shigekawa, M.
(1987)
J. Biol. Chem.
262,
9121-9129
|
| 52.
|
Shimizu, H.,
Borin, M. L.,
and Blaustein, M. P.
(1997)
Cell Calcium
21,
31-41
|
| 53.
|
Herscher, C. J.,
and Rega, A. F.
(1997)
Ann. N. Y. Acad. Sci.
834,
407-409
|
| 54.
|
Sarkadi, B.,
Macintyre, J. D.,
and Gordos, G.
(1978)
FEBS Lett.
89,
78-82
|
| 55.
|
Schilling, W. P.,
Ritchie, A. K.,
Navarro, L. T.,
and Eskin, S. G.
(1988)
Am. J. Physiol.
255,
H219-H227
|
| 56.
|
Laskey, R. E.,
Adams, D. J.,
Johns, A.,
Rubanyi, G. M.,
and van Breemen, C.
(1990)
J. Biol. Chem.
265,
2613-2619
|
| 57.
|
Marletta, M. A.,
Yoon, P. S.,
Iyengar, R.,
Leaf, C. D.,
and Wishnok, J. S.
(1988)
Biochemistry
27,
8706-8711
|
| 58.
|
Buckley, B. J.,
Mirza, Z.,
and Whorton, A. R.
(1995)
Am. J. Physiol.
269,
C757-C765
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
E. Perrier, M.-P. Fournet-Bourguignon, E. Royere, S. Molez, H. Reure, L. Lesage, W. Gosgnach, Y. Frapart, J.-L. Boucher, N. Villeneuve, et al.
Effect of uncoupling endothelial nitric oxide synthase on calcium homeostasis in aged porcine endothelial cells
Cardiovasc Res,
April 1, 2009;
82(1):
133 - 142.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
C. Garcia-Mata, R. Gay, S. Sokolovski, A. Hills, L. Lamattina, and M. R. Blatt
Nitric oxide regulates K+ and Cl- channels in guard cells through a subset of abscisic acid-evoked signaling pathways
PNAS,
September 16, 2003;
100(19):
11116 - 11121.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Koizumi, H. Hikiji, W. S. Shin, T. Takato, S. Fukuda, T. Abe, N. Koshikiya, K. Iwasawa, and T. Toyo-oka
Cell Density and Growth-dependent Down-regulation of Both Intracellular Calcium Responses to Agonist Stimuli and Expression of Smooth-surfaced Endoplasmic Reticulum in MC3T3-E1 Osteoblast-like Cells
J. Biol. Chem.,
February 14, 2003;
278(8):
6433 - 6439.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
E. N Dedkova and L. A Blatter
Nitric oxide inhibits capacitative Ca2+ entry and enhances endoplasmic reticulum Ca2+ uptake in bovine vascular endothelial cells
J. Physiol.,
February 15, 2002;
539(1):
77 - 91.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Wang, J. Chen, Y. Wang, C. W. Taylor, Y. Hirata, H. Hagiwara, K. Mikoshiba, T. Toyo-oka, M. Omata, and Y. Sakaki
Crucial Role of Type 1, but Not Type 3, Inositol 1,4,5-Trisphosphate (IP3) Receptors in IP3-Induced Ca2+ Release, Capacitative Ca2+ Entry, and Proliferation of A7r5 Vascular Smooth Muscle Cells
Circ. Res.,
February 2, 2001;
88(2):
202 - 209.
[Abstract]
[Full Text]
[PDF]
|
 |
|
Copyright © 2000 by the American Society for Biochemistry and Molecular Biology.
|
Advertisement
Advertisement
|